No Cover Image

Journal article 546 views 28 downloads

Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from...

Arlener D Turner, Jason C Ong, Alex Jones Orcid Logo, Alice Tu, Matthew Salanitro, Megan R Crawford

SLEEP, Volume: 46, Issue: 8

Swansea University Author: Alex Jones Orcid Logo

Check full text

DOI (Published version): 10.1093/sleep/zsad128

Abstract

Study Objectives: Neurocognitive impairments in comorbid insomnia and sleep apnea (COMISA) are not well documented. We explored neurocognitive functioning and treatment effects in individuals with COMISA as an ancillary study to a randomized clinical trial. Methods: Participants with COMISA (n = 45;...

Full description

Published in: SLEEP
ISSN: 0161-8105 1550-9109
Published: Oxford University Press (OUP) 2023
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa63885
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2023-07-14T13:18:57Z
last_indexed 2023-07-14T13:18:57Z
id cronfa63885
recordtype SURis
fullrecord <?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>63885</id><entry>2023-07-14</entry><title>Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study</title><swanseaauthors><author><sid>a24e1e2a89b0a9120fe03b481a629edd</sid><ORCID>0000-0003-3600-3644</ORCID><firstname>Alex</firstname><surname>Jones</surname><name>Alex Jones</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2023-07-14</date><deptcode>PSYS</deptcode><abstract>Study Objectives: Neurocognitive impairments in comorbid insomnia and sleep apnea (COMISA) are not well documented. We explored neurocognitive functioning and treatment effects in individuals with COMISA as an ancillary study to a randomized clinical trial. Methods: Participants with COMISA (n = 45; 51.1% female; mean age = 52.07 ± 13.29 years), from a 3-arm randomized clinical trial combining cognitive behavioral therapy for insomnia (CBT-I) and positive airway pressure (PAP) concurrently (CBT-I+PAP) or sequentially, completed neurocognitive testing at baseline, and post-treatment. Using Bayesian linear mixed models, we estimated effects of CBT-I, PAP, or CBT-I+PAP, compared to baseline, and CBT-I+PAP compared to PAP on 12 metrics across five cognitive domains. Results: This COMISA sample had worse neurocognitive performance at baseline than reported for insomnia, sleep apnea, and controls in the literature, though short-term memory and psychomotor speed performance appears intact. When comparing PAP to baseline, performance on all measures was better after treatment. Performance after CBT-I was worse compared to baseline, and only performance in attention/vigilance, executive functioning via Stroop interference and verbal memory was better with moderate–high effect sizes and moderate probability of superiority (61–83). Comparisons of CBT-I+PAP to baseline generated results similar to PAP and comparing CBT-I+PAP to PAP revealed superior performance in only attention/vigilance via psychomotor vigilance task lapses and verbal memory for PAP. Conclusions: Treatment combinations involving CBT-I were associated with poorer neurocognitive performance. These potentially temporary effects may stem from sleep restriction, a component of CBT-I often accompanied by initially reduced total sleep time. Future studies should examine long-term effects of individual and combined COMISA treatment pathways to inform treatment recommendations. Clinical trial: This was an ancillary study from a clinical trial (Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea (MATRICS), which was preregistered at www.clinicaltrials.gov (NCT01785303)).</abstract><type>Journal Article</type><journal>SLEEP</journal><volume>46</volume><journalNumber>8</journalNumber><paginationStart/><paginationEnd/><publisher>Oxford University Press (OUP)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0161-8105</issnPrint><issnElectronic>1550-9109</issnElectronic><keywords>COMISA, insomnia, sleep apnea, CBT-I, PAP, neurocognitive functioning</keywords><publishedDay>14</publishedDay><publishedMonth>8</publishedMonth><publishedYear>2023</publishedYear><publishedDate>2023-08-14</publishedDate><doi>10.1093/sleep/zsad128</doi><url/><notes/><college>COLLEGE NANME</college><department>Psychology School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PSYS</DepartmentCode><institution>Swansea University</institution><apcterm>Not Required</apcterm><funders>This research was supported by a National Heart Lung and Blood Institute (NIH) Research Grant (R01HL114529) awarded to JCO and Supplements to Promote Diversity in Health-Related Research (R01HL114529-03S1) awarded to ADT.</funders><projectreference/><lastEdited>2024-07-29T14:22:40.8098765</lastEdited><Created>2023-07-14T14:15:03.8316158</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Psychology</level></path><authors><author><firstname>Arlener D</firstname><surname>Turner</surname><order>1</order></author><author><firstname>Jason C</firstname><surname>Ong</surname><order>2</order></author><author><firstname>Alex</firstname><surname>Jones</surname><orcid>0000-0003-3600-3644</orcid><order>3</order></author><author><firstname>Alice</firstname><surname>Tu</surname><order>4</order></author><author><firstname>Matthew</firstname><surname>Salanitro</surname><order>5</order></author><author><firstname>Megan R</firstname><surname>Crawford</surname><order>6</order></author></authors><documents><document><filename>63885__28362__f0768679456346f996dd4b5eb086fb87.pdf</filename><originalFilename>63885.AAM.pdf</originalFilename><uploaded>2023-08-23T16:02:11.3257769</uploaded><type>Output</type><contentLength>556387</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2024-05-06T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling v2 63885 2023-07-14 Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study a24e1e2a89b0a9120fe03b481a629edd 0000-0003-3600-3644 Alex Jones Alex Jones true false 2023-07-14 PSYS Study Objectives: Neurocognitive impairments in comorbid insomnia and sleep apnea (COMISA) are not well documented. We explored neurocognitive functioning and treatment effects in individuals with COMISA as an ancillary study to a randomized clinical trial. Methods: Participants with COMISA (n = 45; 51.1% female; mean age = 52.07 ± 13.29 years), from a 3-arm randomized clinical trial combining cognitive behavioral therapy for insomnia (CBT-I) and positive airway pressure (PAP) concurrently (CBT-I+PAP) or sequentially, completed neurocognitive testing at baseline, and post-treatment. Using Bayesian linear mixed models, we estimated effects of CBT-I, PAP, or CBT-I+PAP, compared to baseline, and CBT-I+PAP compared to PAP on 12 metrics across five cognitive domains. Results: This COMISA sample had worse neurocognitive performance at baseline than reported for insomnia, sleep apnea, and controls in the literature, though short-term memory and psychomotor speed performance appears intact. When comparing PAP to baseline, performance on all measures was better after treatment. Performance after CBT-I was worse compared to baseline, and only performance in attention/vigilance, executive functioning via Stroop interference and verbal memory was better with moderate–high effect sizes and moderate probability of superiority (61–83). Comparisons of CBT-I+PAP to baseline generated results similar to PAP and comparing CBT-I+PAP to PAP revealed superior performance in only attention/vigilance via psychomotor vigilance task lapses and verbal memory for PAP. Conclusions: Treatment combinations involving CBT-I were associated with poorer neurocognitive performance. These potentially temporary effects may stem from sleep restriction, a component of CBT-I often accompanied by initially reduced total sleep time. Future studies should examine long-term effects of individual and combined COMISA treatment pathways to inform treatment recommendations. Clinical trial: This was an ancillary study from a clinical trial (Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea (MATRICS), which was preregistered at www.clinicaltrials.gov (NCT01785303)). Journal Article SLEEP 46 8 Oxford University Press (OUP) 0161-8105 1550-9109 COMISA, insomnia, sleep apnea, CBT-I, PAP, neurocognitive functioning 14 8 2023 2023-08-14 10.1093/sleep/zsad128 COLLEGE NANME Psychology School COLLEGE CODE PSYS Swansea University Not Required This research was supported by a National Heart Lung and Blood Institute (NIH) Research Grant (R01HL114529) awarded to JCO and Supplements to Promote Diversity in Health-Related Research (R01HL114529-03S1) awarded to ADT. 2024-07-29T14:22:40.8098765 2023-07-14T14:15:03.8316158 Faculty of Medicine, Health and Life Sciences School of Psychology Arlener D Turner 1 Jason C Ong 2 Alex Jones 0000-0003-3600-3644 3 Alice Tu 4 Matthew Salanitro 5 Megan R Crawford 6 63885__28362__f0768679456346f996dd4b5eb086fb87.pdf 63885.AAM.pdf 2023-08-23T16:02:11.3257769 Output 556387 application/pdf Accepted Manuscript true 2024-05-06T00:00:00.0000000 true eng
title Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study
spellingShingle Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study
Alex Jones
title_short Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study
title_full Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study
title_fullStr Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study
title_full_unstemmed Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study
title_sort Neurocognitive functioning in comorbid insomnia and sleep apnea patients is better after positive airway pressure therapy, but worse after cognitive behavioral therapy for insomnia: exploratory analysis of cognitive outcomes from the Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea study
author_id_str_mv a24e1e2a89b0a9120fe03b481a629edd
author_id_fullname_str_mv a24e1e2a89b0a9120fe03b481a629edd_***_Alex Jones
author Alex Jones
author2 Arlener D Turner
Jason C Ong
Alex Jones
Alice Tu
Matthew Salanitro
Megan R Crawford
format Journal article
container_title SLEEP
container_volume 46
container_issue 8
publishDate 2023
institution Swansea University
issn 0161-8105
1550-9109
doi_str_mv 10.1093/sleep/zsad128
publisher Oxford University Press (OUP)
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str School of Psychology{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Psychology
document_store_str 1
active_str 0
description Study Objectives: Neurocognitive impairments in comorbid insomnia and sleep apnea (COMISA) are not well documented. We explored neurocognitive functioning and treatment effects in individuals with COMISA as an ancillary study to a randomized clinical trial. Methods: Participants with COMISA (n = 45; 51.1% female; mean age = 52.07 ± 13.29 years), from a 3-arm randomized clinical trial combining cognitive behavioral therapy for insomnia (CBT-I) and positive airway pressure (PAP) concurrently (CBT-I+PAP) or sequentially, completed neurocognitive testing at baseline, and post-treatment. Using Bayesian linear mixed models, we estimated effects of CBT-I, PAP, or CBT-I+PAP, compared to baseline, and CBT-I+PAP compared to PAP on 12 metrics across five cognitive domains. Results: This COMISA sample had worse neurocognitive performance at baseline than reported for insomnia, sleep apnea, and controls in the literature, though short-term memory and psychomotor speed performance appears intact. When comparing PAP to baseline, performance on all measures was better after treatment. Performance after CBT-I was worse compared to baseline, and only performance in attention/vigilance, executive functioning via Stroop interference and verbal memory was better with moderate–high effect sizes and moderate probability of superiority (61–83). Comparisons of CBT-I+PAP to baseline generated results similar to PAP and comparing CBT-I+PAP to PAP revealed superior performance in only attention/vigilance via psychomotor vigilance task lapses and verbal memory for PAP. Conclusions: Treatment combinations involving CBT-I were associated with poorer neurocognitive performance. These potentially temporary effects may stem from sleep restriction, a component of CBT-I often accompanied by initially reduced total sleep time. Future studies should examine long-term effects of individual and combined COMISA treatment pathways to inform treatment recommendations. Clinical trial: This was an ancillary study from a clinical trial (Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea (MATRICS), which was preregistered at www.clinicaltrials.gov (NCT01785303)).
published_date 2023-08-14T14:22:39Z
_version_ 1805919830217326592
score 11.037603

Similar Items